-
Yes! There is emerging research exploring the use of psychedelic microdosing, including Psilocybin and Amanita , as a potential approach to managing ADHD symptoms in adults.
Preliminary studies are suggesting that microdosing psychedelics like Psilocybin and Amanita may offer benefits in managing certain ADHD symptoms, particularly in emotion regulation and ability to regulate stress as an underlying factor of ADHD.
-
-
-
Key Findings from Recent Studies:
A naturalistic study examined adults with ADHD who self-initiated psychedelic microdosing over four weeks. Participants reported reduced ADHD symptoms, increased mindfulness—particularly in describing and non-judging internal experiences—and decreased neuroticism. Other personality traits remained unchanged. The study's design relied on self-reported data without experimental control, limiting definitive conclusions. Nonetheless, findings suggest potential therapeutic benefits of microdosing for ADHD, warranting further investigation through controlled clinical trials.
-
-
Naturalistic Prospective Studies:A study published in European Psychiatry in 2024 examined adults with severe ADHD symptoms who self-initiated microdosing with psychedelics like psilocybin or LSD. Over a four-week period, participants reported improvements in emotion regulation strategies, such as increased cognitive reappraisal and decreased expressive suppression. Some aspects of empathy, like perspective-taking, also showed enhancement.
-
-
Mindfulness and Personality Traits:
Another study investigated the effects of four weeks of microdosing on mindfulness and personality traits in adults with ADHD. Results indicated increased trait mindfulness and decreased neuroticism post-microdosing, suggesting potential benefits in emotional regulation and stress response. However, other personality traits remained unchanged, and the study emphasised the need for placebo-controlled trials to confirm these findings.
